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PHARMACOLOGY
The synthesized compounds were evaluated for analgesic, local anaesthetic and antifungal activity. Acute oral toxicity test was performed for all the synthesized compounds as per organization of economic co-operation and development (OECD) guidelines. Statistical analysis (ANOVA followed by Dunnett's t-test) was performed for analgesic activity to ascertain the significance of the exhibited activity. The test compounds and the standard drugs were administered in the form of a suspension (1% carboxy methyl cellulose as vehicle) in the same route of administration.
Animals Inbred wistar albino mice (20-30 g) was used. They were kept in colony cages at 25Ϯ2°C, relative humidity 45-55% under 12 h light and dark cycle. The animals were fed with standard animal feed and water ad libitum. All the animals were acclimatized for a week before use. Small frogs (Rana tigrina; 100-150 g) was procured locally and used on the same day.
Acute Oral Toxicity Acute oral toxicity 16) was performed as per OECD-423 guidelines (acute toxic class method). Wistar albino mice (nϭ3) of either sex selected by random sampling technique was used for the study. The animals were kept fasting for 3-4 h providing only water, after which the test compounds (suspended in olive oil) were administered orally at the dose level of 5 mg/kg by intragastric tube and observed for 3 d. If mortality was observed in 2-3 animals, then the dose administered was assigned as toxic dose. If mortality was observed in one animal, then the same dose was repeated again to confirm the toxic dose. If mortality was not observed, the procedure was repeated for further higher doses such as 50, 300 and 2000 mg/kg.
Analgesic Activity The analgesic activity 17) was determined by tail immersion method. Wistar albino mice (nϭ6) of either sex selected by random sampling technique was used for the study. Diclofenac sodium at the dose of 20 mg/kg was administered as standard drug for comparison. The test compounds at 2 dose levels (30 and 60 mg/kg) were administered orally by intragastric tube. The animals were held in position by a suitable restrainer with the tail extending out and the tail (up to 5 cm) was then dipped in a beaker of water maintained at 55Ϯ0.5°C. The time in seconds taken to withdraw the tail clearly out of water was taken as the reaction time. The first reading (0 min) was taken immediately after the administration of the test compound and subsequent reaction time was recorded at 30, 60, 120 and 180 min after the administration of compounds. A cut off point of 15 s was observed to prevent the tail damage. The data are presented in Table 2 .
Local Anaesthetic Activity The local anaesthetic activity 18) was determined by nerve block anaesthesia in frogs (nϭ6). The animal was decerebrated and the upper part of the spinal cord was destroyed with a pithing needle. The abdomen was cut open and all the abdominal organs was removed, so that a pouch (sac) was made to expose the spinal nerves. The animal was fixed on a frog board with two of its hind legs hanging free from the board. The right leg was immersed in a beaker containing 0.1 N hydrochloric acid and the time taken for the absence of withdrawal was noted. The same procedure was repeated for the left leg also. The sac was filled with 2 ml of the test compounds at 0.5, 1, 2% w/v (suspended in 1% carboxy methyl cellulose) and the absence of withdrawal reflex was observed at the interval of 30 s. The leg was washed with normal saline between exposure to acid. Lignocaine (0.5, 1, 2% w/v) was taken as the standard drug for comparison. The data are presented in Table 3 .
Antifungal Activity The antifungal activity 19) of the compounds was tested against C. albicans and A. niger using sabourand dextrose agar medium. The sterilized (antoclaved at 120°for 30 min) medium (40-50°) was inoculated (1 ml/100 ml of medium) with the suspension of the microorganism (matched to McFarland barium sulphate standard) and poured into a petridish to give a depth of 3-4 mm. The paper impregnated with the test compounds (1 mg/ml in dimethyl sulphoxide) was placed on the solidified medium. The plates were preincubated for 1 h at room temperature and incubated at 37°C for 48 h for antifungal activity. Ketoconazole (100 mg/disc) was used as standard. The observed zone of inhibition is presented in Table 4 . DISCUSSION   Compounds 1-4, 8-12, 14-20 did not cause mortality up to 2000 mg/kg and were considered as safe (x-unclassified). Compounds 5-7, 13, 17, 18 and 21 produced mortality at 2000 mg/kg and they were considered as class-4 compounds.
RESULTS AND
Compounds 1-7 exhibited significant analgesic and local anaesthetic activity. Graded dose response was observed for the active compounds. 2-(4-Methylphenyl)-3-methyl-6-(4-chlorophenyl)-piperidin-4-one 2 exhibited the highest analgesic and local anaesthetic activity. It was observed that when the 4-keto functionality was condensed to form thiosemicarbazones (8) (9) (10) (11) (12) (13) (14) or oximes (15) (16) (17) (18) (19) (20) (21) , the resulting compounds did not exhibit analgesic and local anaesthetic activity. The predominant and stable configuration 20) of 2,6-diaryl-3-substituted-piperidones is chair form with the substituents in the equatorial positions. The analgesic and local anaesthetic activity of compounds 1-7 may be attributed to this favourable configuration. The introduction of thiosemicarbazino (8) (9) (10) (11) (12) (13) (14) or oxime (15-21) substitution probably leads to unfavourable configuration of the molecules resulting in compounds completely devoid of analgesic and local anaesthetic activity. Therefore, the 4-keto moiety of the present series of piperidones seems to play a vital role in the analgesic and local anaesthetic activity of the compounds. Compounds 8-13, 15-21 exhibit antifungal activity against A. niger. Antifungal activity against C. albicans was only observed with 2-(4-dimethylaminophenyl)-3-methyl-6-(4-chlorophenyl)-piperidin-4-oxime 20. 2-(4-Methylphenyl)-3-methyl-6-(4-hydroxyphenyl)-piperidin-4-oxime 21 and 2-(4-methoxyphenyl)-3-methyl-6-(4-chlorophenyl)-piperidin-4-oxime 17 was found to exhibit equivalent antifungal activity against A. niger compared to ketoconazole. The compounds with 4-keto group (1-7) did not exhibit antifungal activity.
In the present series of compounds, the oxime substitution at the 4 position and 4-dimethylamino phenyl substitution at the 2 position seems to play a vital role in the activity against C. albicans. The activity against A. niger was significantly higher for oximes (15) (16) (17) (18) (19) (20) (21) than the corresponding thiosemicarbazones (8) (9) (10) (11) (12) (13) (14) . The presence of thiosemicarbazino or oxime functionality at the 4-position of the present series of piperidones seems to possess an important role in the antifungal activity of the compounds.
